Insilico Medicine Eyes Hong Kong IPO After $110M Funding, AlphaDroid's AI Robotics Launched - Life AI Weekly #9

Hi there,

In this edition of Life AI Weekly, we're diving into the latest advancements in healthcare and life sciences AI. AlphaDroid has unveiled new AI robotics aimed at transforming Indian healthcare, while Avatar Medical's software has gained CE marking, signaling its compliance with EU safety standards. Meanwhile, DeCloak Intelligences is teaming up with National Taiwan University Hospital to present an AI privacy system at NVIDIA GTC 2025.

On the business front, Allo Health has raised INR 16 Cr to enhance AI-driven sexual health services, and Insilico Medicine is eyeing a Hong Kong IPO following a successful $110 million funding round. These developments highlight the growing intersection of AI technology and healthcare, promising to bring innovative solutions to the industry.

Allo Health, a Bengaluru-based startup, has secured INR 16 Cr in a Pre-Series A funding round led by Zerodha's Rainmatter. The funds will be used to expand its clinic network and enhance AI-driven treatment protocols in India. Insilico Medicine Inc., an AI drug startup, is considering a Hong Kong IPO following a $110 million funding round, raising its valuation to over $1 billion. The company plans to enhance its AI platform and advance its drug candidate for idiopathic pulmonary fibrosis. Nimblemind.ai has raised $2.5 million to improve the structuring of clinical data for healthcare providers, enhancing its AI capabilities. The funding, led by Bread & Butter Ventures, will support the expansion of its platform and AI models. Baird Medical received the 'Most Valuable Investment Award' for its AI Tumor Ablation Surgical Robot at the China Medical Industry Innovation Competition. The robot aims to improve surgical precision and efficiency. brain.space has announced securing $11 million in Series A funding led by Toyota Ventures. The funds will aid in developing their Brain-Data-as-a-Service ecosystem to enhance understanding of human behavior through mental modeling.

Stäubli Robotics will introduce Sterimove, the first cleanroom mobile robot for the pharmaceutical industry, at INTERPHEX 2025 in New York City. Biolexis Therapeutics has resolved the structure of BLX-7006, an oral GLP-1 receptor agonist, using cryo-electron microscopy. This marks a novel activation mechanism, with human trials expected in Q3 2025. Gene therapy company MeiraGTx and AI firm Hologen have formed a joint venture to develop AI-driven gene therapies for Parkinson's disease and obesity, with an initial funding of $200 million. South Korean startup Galux has released a study showcasing its AI platform, GaluxDesign, which successfully designed antibodies for six therapeutic targets, including one without an experimentally resolved structure.

Icahn School of Medicine at Mount Sinai has developed an AI model, PFTSleep, to enhance sleep stage classification and support clinical tools for sleep disorder detection. Harvard T.H. Chan School of Public Health is developing AI models to improve resilience against infectious disease outbreaks and environmental stressors. Osaka University researchers have created an AI model to determine biological age from a small blood sample by analyzing steroid hormone metabolism.

Shiru and GreenLab have announced a partnership to commercialize sustainable food proteins using GreenLab's corn expression system. The collaboration aims to enhance manufacturing capabilities and provide scalable solutions for high-value proteins in the food industry. LabCentral and C10 Labs have launched a new AI BioHub in Kendall Square, Cambridge, to support life sciences startups with AI resources and lab space. The project is backed by a $1.9 million grant from the Massachusetts Technology Collaborative's Innovation Institute.

AlphaDroid has launched AI-driven robotics for Indian healthcare, showcased at the International Patient Safety Conference 2025. Avatar Medical received CE marking for its 3D and XR imaging software in Europe. DeCloak Intelligences and National Taiwan University Hospital will present their AI Privacy System at NVIDIA GTC 2025.